Market Research Logo

Switzerland Pharmaceuticals & Healthcare Report Q1 2018

Switzerland Pharmaceuticals & Healthcare Report Q1 2018

BMI View: The Swiss pharmaceutical market is slowly recovering from the effects of medicine price cuts and generic drug promotion by the government in recent years. We expect sales of high-value innovative medicines will continue to decline in 2018 before returning to growth in 2019, albeit marginally. Over the longer-term, medicine sales will be driven by an ageing population coupled with the country's generous healthcare system. However, this also increases the likelihood of the government implementing further growth-inhibiting measures for drugmakers to manage the rising cost of healthcare.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Switzerland 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Switzerland 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Switzerland 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Switzerland 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Switzerland 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Switzerland 2015-2021)
Industry Risk/Reward Index
Europe - Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: 2013 & 2014: Health Insurance Premiums
Table: Healthcare Resources (Switzerland 2011-2016)
Table: Healthcare Personnel (Switzerland 2011-2016)
Table: Healthcare Activity (Switzerland 2011-2016)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Novartis
Roche
Demographic Forecast
Table: Population Headline Indicators (Switzerland 1990-2025)
Table: Key Population Ratios (Switzerland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Switzerland 1990-2025)
Table: Population By Age Group (Switzerland 1990-2025)
Table: Population By Age Group % (Switzerland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report